Pages that link to "Q37671051"
Jump to navigation
Jump to search
The following pages link to Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects. (Q37671051):
Displaying 50 items.
- Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease (Q26750370) (← links)
- The pathobiology of vascular dementia (Q27006033) (← links)
- Hypertension: a harbinger of stroke and dementia (Q27027494) (← links)
- Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease (Q28082612) (← links)
- Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review (Q30235254) (← links)
- The blood brain barrier in Alzheimer's disease. (Q30239749) (← links)
- The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies (Q30830414) (← links)
- Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice (Q31122715) (← links)
- Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias (Q31153910) (← links)
- Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND). (Q31159582) (← links)
- Lipid and Alzheimer's disease genes associated with healthy aging and longevity in healthy oldest-old (Q33591262) (← links)
- Memory is preserved in older adults taking AT1 receptor blockers (Q33604279) (← links)
- Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden (Q33770441) (← links)
- Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention (Q33822159) (← links)
- Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions (Q33965410) (← links)
- Longitudinal effects of metabolic syndrome on Alzheimer and vascular related brain pathology (Q34296138) (← links)
- Hypertension drives parenchymal β-amyloid accumulation in the brain parenchyma (Q34418827) (← links)
- Cognitive health begins at conception: addressing dementia as a lifelong and preventable condition (Q35046906) (← links)
- What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus (Q35129501) (← links)
- Effects of vascular risk factors and APOE ε4 on white matter integrity and cognitive decline (Q35211068) (← links)
- ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ε2 carriers (Q35572281) (← links)
- Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'. (Q35581060) (← links)
- Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults (Q35598088) (← links)
- Group-based exercise and cognitive-physical training in older adults with self-reported cognitive complaints: The Multiple-Modality, Mind-Motor (M4) study protocol. (Q35895383) (← links)
- Blood pressure interacts with APOE ε4 to predict memory performance in a midlife sample (Q35995579) (← links)
- The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage. (Q36044903) (← links)
- The Age-Dependent Relationship between Blood Pressure and Cognitive Impairment: A Cross-Sectional Study in a Rural Area of Xi'an, China (Q36082923) (← links)
- Magnetic Resonance Imaging of Cardiovascular Function and the Brain: Is Dementia a Cardiovascular-Driven Disease? (Q36385542) (← links)
- Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP (Q36593230) (← links)
- Impact of lifestyle dimensions on brain pathology and cognition (Q36687806) (← links)
- Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study (Q36763368) (← links)
- Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects (Q36933792) (← links)
- White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration (Q37106748) (← links)
- Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future (Q37184753) (← links)
- Pulse Pressure Is Associated With Early Brain Atrophy and Cognitive Decline: Modifying Effects of APOE-ε4. (Q37207699) (← links)
- Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities (Q37252248) (← links)
- Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder? (Q37285389) (← links)
- Cortical thickness mediates the effect of β-amyloid on episodic memory (Q37623176) (← links)
- Correlation of Cerebral Microbleed Distribution to Amyloid Burden in Patients with Primary Intracerebral Hemorrhage. (Q37708191) (← links)
- Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association (Q37715160) (← links)
- Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease (Q38116974) (← links)
- Animal models of Alzheimer disease: historical pitfalls and a path forward (Q38209146) (← links)
- A major role for cardiovascular burden in age-related cognitive decline (Q38316448) (← links)
- Obesity and Aging: Consequences for Cognition, Brain Structure, and Brain Function (Q38536860) (← links)
- Defeating Alzheimer's disease and other dementias: a priority for European science and society (Q38778638) (← links)
- APOEε4 Genotype and Hypertension Modify 8-year Cortical Thinning: Five Occasion Evidence from the Seattle Longitudinal Study. (Q38819201) (← links)
- Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex (Q40032135) (← links)
- Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition (Q40247745) (← links)
- Contribution of cerebrovascular health to the diagnosis of Alzheimer disease. (Q42389282) (← links)
- Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment (Q42653687) (← links)